Abstract
Primary Sjögren’s syndrome is complicated by a vast array of neuromuscular complications which recent evidence suggests have an immunologically mediated basis. Neuromuscular complications include involvement of the central and peripheral nervous systems, as well as the skeletal muscle system. Musculoskeletal complaints in Sjögren’s syndrome are common symptoms. Inflammatory myopathy (i. e. myositis) is less common, but well documented, and may be accompanied by vascular inflammation (Table 1), (see Chapter II. B. 6.).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alexander GE, Provost TT, Stevens MB, Alexander EL ( 1981 a) Sjögren’s syndrome: Central nervous system manifestations. Neurology 31: 1391–1396
Alexander EL, Provost TT (1981 b) Ro(SS-A) and La(SS-B) antibodies. Springer Semin Immunopathol 4: 253–273
Alexander EL, Craft C, Dorsch C, Moser RL, Provost TT, Alexander GE (1982 a) Necrotizing arteritis and spinal subarachnoid hemorrhage in Sjögren’s syndrome. Ann Neurol 11: 632–635
Alexander EL, Hirsch TJ, Arnett FC, Provost TT, Stevens MB (1982b) Ro(SS-A) and La(SS-B) antibodies in the clinical spectrum of Sjögren’s syndrome. J Rheumatol 9: 239–246
Alexander EL, Provost TT, Stevens MB, Alexander GE (1982 c) Neurologic complications of primary Sjögren’s syndrome. Medicine 61: 247–257
Alexander EL, Josifek L, Provost TT, Alexander GE (1982d) Myositis/vasculitis in primary Sjögren’s syndrome ( SS ). Arthritis Rheum 25: S15
Alexander EL, Alexander GE (1983 a) Aseptic meningitis in primary Sjögren’s syndrome. Neurology 33: 593–598
Alexander EL, Arnett FC, Provost TI’, Stevens MB (1983b) Sjögren’s syndrome: Association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med 98: 155–159
Alexander EL, Murphy ED, Roths JB, Alexander GE (1983 c) Congenic autoimmune murine models of central nervous disease in connective tissue disorders. Ann Neuro114: 242–248
Alexander EL, Provost TT ( 1983 d) Cutaneous manifestations of primary Sjögren’s syndrome: A reflection of vasculitis and association with anti-Ro(SS-A) antibodies. J Invest Dermatol 80: 386–391
Alexander EL (1986 a) Central nervous system (CNS) manifestations of primary Sjögren’s syndrome: An overview. Scandinavian J Rheum, In press
Alexander EL (1986 b) Immunopathologic mechanisms of inflammatory vascular disease in primary Sjögren’s syndrome. Scandinavian J Rheum, In press
Alexander EL, Beall S, Provost TT, Patronas M, McFarland HF ( 1986 c) Magnetic resonance imaging (MRI) in primary Sjögren’s syndrome with central nervous system disease ( CNS-SS ): New clues to pathogenesis. Arthritis Rheum 29: S63
Alexander EL, Lijewski JE, Jerdan MS, Alexander GE (1986d) Evidence for an immunopathogenic basis for central nervous disease in primary Sjögren’s syndrome. Arthritis Rheum 29: 1223–1231, 1986.
Alexander EL, Malinow K, Lijewski JE, Jerdan MS, Provost TI’, Alexander GE (1986e) Primary Sjögren’s syndrome with central nervous system dysfunction mimicking multiple sclerosis. Ann Intern Med 104: 323–330
Alexander EL, Provost TT (1986f) Sjögren’s syndrome: Association of cutaneous vasculitis with nervous system disease. Arch Derm, In press
Alexander EL, Provost TT, Bias WB, McFarland HF (1986g) Unique immunogenetic associations distinguish Sjögren’s syndrome central nervous system disease (CNS-SS) from multiple sclerosis ( MS ). Arthritis Rheum 29: S63
Alexander EL, Sanders ME, Frank MM, Joiner KA (1986h) Activated terminal complement (SC5b-9) in the sera of Sjögren’s syndrome patients with central nervous system disease ( CNSSS ). Arthritis Rheum 29: S37
Austin HA III, Klippel JH, Balow JE, Le Riche NGH, Steinberg AD, Plotz PH, Decker JL (1986) Therapy of lupus nephritis - Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314: 614–619
Barrett L, Drayer B, Shin C (1985) High-resolution computed tomography in multiple sclerosis. Ann Neuro 117: 33–38
Bloch KJ, Buchanan WW, Wohl JJ, Bunim JJ (1965) Sjögren’s syndrome: A clinical, pathological and serological study of 62 cases. Medicine (Baltimore) 44: 187–231
Bohan A, Peter JB, Bowman RL, Pearson CM (1977) A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 56: 255–285
Bunim JJ (1961) A broader spectrum of Sjögren’s syndrome and its pathogenetic implications. Ann Rheum Dis 20: 1–10
Chad D, Good P, Adelman L, Bradley WG, Mills J (1982) Inclusion body myositis associated with Sjögren’s syndrome. Arch Neurol 39: 186–188
Cummings JL, Benson DF (1984) Subcortical dementia: review of an emerging concept. Arch Neurol 41: 874–849
Cyong JC, Witkin SS, Rieger B, Barbarese E, Good RA, Day NK (1982) Antibody independent complement activation by myelin via the classical complement pathway. J Exp Med 155: 587
Daniels TE (1984) Labial salivary gland biopsy in Sjögren’s syndrome. Arthritis Rheum 27: 147–156
De la Monte SM, Hutchins GM, Gupta PK (1983) Polymorphous meningitis with atypical mononuclear cells in Sjögren’s syndrome. Ann Neurol 14: 455–461
Greenspan JS, Daniels TE, Talai N, Sylvester RA (1974) The histopathology of Sjögren’s syndrome in labial salivary gland biopsies. Oral Surg 37: 217–229
Harley JB, Alexander EL, Bias WB, Fox OF, Provost T’, Reichlin M, Yamagata H, Arnett FC (1986 a) Anti-Ro(SS-A) and anti-La(SS-B) in patients with Sjögren’s syndrome. Arthritis Rheum 29: 196–206
Harley JB, Reichlin M, Arnett FC, Alexander EL, Bias WB, Provost TT (1986 b) Gene interaction at HLA-DR enhances autoantibody production in primary Sjögren’s syndrome. Science 232: 1145–1147
Holm S (1949) Keratoconjunctivitis sicca and the sicca syndrome. Acta Ophthalmol Supp 133: 13–16
Kaltreider HB, Talal N (1969) The neuropathy of Sjögren’s syndrome. Trigeminal nerve involvement. Ann Intern Med 70: 751–762
Kremer J, Rynes R, Bartholomew L et al (1981) Non-organic non-psychotic psychopathology ( NONPP) in patients with systemic lupus erythematosus. Semin Arthritis Rheum 11: 182–189
Lachar D (1978) The MMPI: Clinical assessment and automated interpretation. Los Angeles: Western Psychological Services, p 46
Liang MH, Rogers M, Larson M et al (1984) The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 27: 13–19
Maddison PJ, Mogavero H, Provost TT, Reichlin M (1979) The clinical significance of autoantibodies to certain soluble cytoplasmic antigens in systemic lupus erythematosus and other connective tissue diseases. J Rheum 6: 189–195
Malinow KL, Molina R, Gordon B, Seines OA, Provost Tr, Alexander EL (1985) Neuropsychiatric dysfunction in primary Sjögren’s syndrome. Ann Intern Med 103: 344–349
Malinow KL, Yannakakis GD, Glusman SM, Edlow DR, Griffin J, Pestronk A, Powell DL, Ramsey-Goldman R, Eidelman BH, Medsger TA, Alexander EL (1986) Subacute sensory neuropathy secondary to dorsal root ganglionitis in primary Sjögren’s syndrome. Ann Neurol, 20: 535–537
Masi AT, Rodnan GP, Medsger TA et al (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581–590
Molina R, Provost TT, Alexander EL (1985 a) Peripheral inflammatory vascular disease in Sjögren’s syndrome: association with nervous system complications. Arthritis Rheum 28: 1341–1347
Molina R, Provost TT, Alexander EL (1985 b) Two histopathologic prototypes of inflammatory vascular disease in Sjögren’s syndrome: differential association with seroactivity to rheumatoid factor and antibodies to Ro(SS-A) and with hypocomplementemia. Arthritis Rheum 28: 1251–1258
Molina R, Provost TT, Arnett FC, Bias WB, Hochberg MC, Wilson RW, Alexander EL (1986) Primary Sjögren’s syndrome ( SS) in men - clinical, serologic and immunogenetic features. Am J Med 80: 23–31
Olsson JE, Link H, Muller R (1976) Immunoglobulin abnormalities in multiple sclerosis: relation to clinical parameters: disability, duration and age of onset. J Neurol Sci 27: 233–245
Peyronnard JM, Charron L, Beaudet F, Couture F (1982) Vasculitic neuropathy in rheumatoid disease and Sjögren’s syndrome. Neurology 32: 839–845
Pittsley RA, Talai N (1980) Neuromuscular complications of Sjögren’s syndrome. Chapter 19, pp 419–433
Raskin RI, Tesar JT, Lawless OJ (1981) Hypokalemic periodic paralysis in Sjögren’s syndrome. Arch Intern Med 141: 1671
Ringel SP, Forstot JZ, Tan EM, Wehling C, Griggs RC, Butcher D (1982) Sjögren’s syndrome and polymyositis or dermatomyositis. Arch Neurol 39: 157–163
Ropes MW, Bennett GA, Cobb S (1958) Diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9: 175–176
Rutan G, Martinez AJ, Fieshko JT, Van Thiel DH (1986) Primary biliary cirrhosis, Sjögren’s syndrome, and transverse myelitis. Gastroenterology 90: 206–210
Sanders ME, Koski CL, Robbins D, Shin ML, Frank MM, Joiner KA (1986) Activated terminal complement in cerebrospinal fluid in Guillain-Barre Syndrome and multiple sclerosis. J Immuno 1135: 1–4
Seines OA, Gordon B, Malinow K, Alexander EL (1985) Cognitive dysfunction in primary Sjögren’s syndrome. Neurology 35 (Suppl 1): 179
Shearn M (1971) Sjögren’s syndrome. WB Saunders, Philadelphia
Sheldon JH (1938) Sjögren’s syndrome associated with pigmentation and sclerodenna of the legs. ProcRoy Soc Med 32: 255–256
Silberberg DH, Drachman DA (1962) Late-life myopathy occurring with Sjögren’s syndrome. Arch Neurol 6: 428–438
Sjögren H (1935) Zur Kenntnis der keratoconjunctivitis sicca. II. Allgemeine Symptomatologie und Atiologie. Acta Ophthal (Kbh) 13: 1–39
Strickland RW, Tesar JT, Berne BH et al (1984) The prevalence of Sjögren’s syndrome and associated rheumatic diseases in an elderly population. Arthritis Rheum 27: S45
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271–1277
Vanguri P, Koski CL, Silverman B, Shin ML (1982) Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin specific antibodies. Proc Natl Acad Sci USA 79: 3290
Von Bekesy G (1964) Duplicity theory of taste. Science 145: 834–835
Whaley K, Webb J, McAvoy BA, Hughes GRV, Lee P, MacSween RNM, Buchanan WW (1973) Sjögren’s syndrome. II. Clinical associations and immunological phenomena. Quart J Med 42: 513–548
Whitaker JN, Engel WK (1972) Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med 286: 333–338
Wilson R, Provost TT, Bias WB, Alexander EL, Edlow DW, Hochberg MC, Stevens MB, Arnett FC (1984) Sjögren’s syndrome: Influence of multiple HLA-D region alloantigens on clinical and serologic expression. Arthritis Rheum 27: 1245–1253
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Alexander, E.L. (1987). Neuromuscular Complications of Primary Sjögren’s Syndrome. In: Talal, N., Moutsopoulos, H.M., Kassan, S.S. (eds) Sjögren’s Syndrome. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-50118-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-50118-0_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-50120-3
Online ISBN: 978-3-642-50118-0
eBook Packages: Springer Book Archive